This study aimed to demonstrate the effect of Enhanced Amino Acid (AA) compositions on human cognitive functioning. The research study design included an open, randomized, enhanced vs non-enhanced placebo-controlled trial for 90 days. Participants in the study were measured initially, randomly divided into three groups (experimental, control, and placebo), and measured 30, 60, and 90 days later. 80 healthy people aged 35-65 (men and women) participated in the study and were randomly divided into three groups. 40 used AA composition enhanced in plasma tachyon igniton treatment (experimental), 20 people used the same AA non-enhanced composition (control), while 20 used a placebo. In the second (after 30 days), third (after 60 days), and fourth (after 90 days) tests. The results showed that using AA compositions during the longitude period significantly affected cognitive functions in particular memory, speed of reactions and attention and that AAs processed by radiation of a cold plasma had an even more substantial effect.
Amino acids; Cognitive functions; Cold plasma; Ignitons, Memory improvement; Non-doping methods
AA: Amino Acid
5-HTP : 5-Hydroxytryptophan
NADH: Nicotinamide Adenine Dinucleotide + Hydrogen
CoQ10: Coenzyme Q10
A widely recognized fact is that Amino Acids (AAs) serve as cell signalling molecules and play a crucial role in regulating gene expression and the protein phosphorylation cascade. Moreover, AA has a crucial role as a precursor in the synthesis of hormones and low-molecular-weight nitrogenous compounds that possess significant biological significance [1,2]. Nevertheless, heightened concentrations of AA and its derivatives have been identified as causative elements in the development of neurological diseases, oxidative stress, and cardiovascular disease. Therefore, achieving an ideal equilibrium between AA intake in the diet and its circulation is of utmost importance for maintaining overall body homeostasis.
An increasing corpus of scholarly works has contributed to the emergence of a novel concept known as functional AAs. This idea refers to AAs that play a crucial role in regulating essential metabolic pathways, hence enhancing the overall well-being, survival, growth, development, lactation, and reproduction of animals [3]. AAs have a crucial role in cognitive functioning and have potential medicinal uses [4]. The inclusion of one or a combination of AA supplements in one's diet has the potential to promote overall health and enhance well-being. The utilization of 5-HTP and l-tyrosine, which are AA precursors of serotonin and dopamine respectively, has been shown to be efficacious in alleviating symptoms of low mood [5-7]. A study conducted by researchers [8] provided evidence in favour of the utilization of oral amino AA supplementation to enhance cognitive performance. Tryptophan is an essential amino acid that plays a crucial role in brain function due to its activity as a precursor for the synthesis of the neurotransmitter serotonin (5-hydroxytryptamine). Numerous studies have demonstrated the positive effects of tryptophan on cognition [9-12]. According to a study [13], the combination of the non-proteinic amino acid L-theanine and caffeine has been demonstrated to enhance focused attention during a cognitively demanding activity. According to recent research [14], it has been indicated that the consumption of the seven necessary AAs (namely leucine, phenylalanine, and lysine in granular powder form) has been associated with enhanced attention, cognitive flexibility, and psychosocial functioning. These positive effects are believed to have potential in mitigating cognitive decline (Figure 1).
Plasma is a state of matter characterized by the presence of ions and electrons. The substance in question is a gaseous state characterized by partial ionization. The composition of the substance consists of a combination of neutral atoms, atomic ions, electrons, molecular ions, and molecules in both excited and ground states. The quantity of particles present in plasma is contingent upon the gas pressure under which it was generated. The charges, both positive and negative, exhibit a state of equilibrium, resulting in a significant proportion of these charges being electrically neutral.
Figure 1: Roles of AA in nutrition and whole-body homeostasis [3].
The utilization of cold plasma in food preparation has gained significant popularity in recent times [15]. The purpose of its application is to mitigate the occurrence of microbial contaminations [16]. There are several notable benefits associated with the extension of product shelf-life [17], enhancement of food drying performance [18], and the potential preservation or improvement of food's organoleptic and biomolecular qualities following processing [19].
This paper presents the findings from a study that examines the impact of AA compositions on human cognitive abilities, specifically focusing on the enhanced effects of AAs treated with cold plasma ignitons enhancement compared to untreated AAs.
An open, randomized, placebo-controlled trial for 90 days was conducted. Participants were measured initially, randomly divided into three groups (experimental, control, and placebo), and measured 30, 60, and 90 days later the start of the study.
Eighty adults of different sexes, ages, and professions, aged 50 +/- 14 years, participated in the study. The study included adults meeting the following criteria:
There was no early abandonment of the subjects from the experiment.
Participants were randomly selected into three groups:
Group 1: 40 people consumed daily amino acid composition processed with plasma ignitons enhancement for three months.
Group 2: 20 people for three months consumed daily same amino acid composition without enhancement.
Group 3: 20 people for three months consumed daily placebo.
Initially and every month, participants had access to online computer tests that were designed to test cognitive functions. The results of the tests were evaluated and statistically processed in the SPSS program by the research team.
The amino acid composition had the following content:
The ethics committee of the Federal State Budget Institution "Saint-Petersburg Scientific-Research Institute for Physical Culture," St. Petersburg, Russia, approved the study protocol. All participants signed an informed consent form, where a written and oral explanation of the research protocol was provided.
Statistical Analysis
Several cognitive computer tests were designed with the objective of measuring the cognitive functions of the participants. The main cognitive functions measured were: – memory, speed of reactions, and attention. The following online computer tests were designed for this study:
Table 1 presents an overview of the tests after 30 days. We can see high level of improvement of the group using Amino Acids enhanced in plasma (Igni Cognition) compared with two other groups.
Cognitive test |
Amino Acids enhanced (Igni Cognition) |
Amino Acids non-enhanced |
Placebo |
Overall memory |
100% improvement |
20% improvement |
1% improvement |
Short Term memory |
28% improvement |
10% improvement |
1% improvement |
Operational memory |
25% improvement |
14% improvement |
8% improvement |
Attention |
51% improvement |
0% improvement |
9% improvement |
Quality of performance |
83% improvement |
9% improvement |
39% improvement |
Table 1: Clinical tests results for 80 volunteers results for 30 days. Group taken enhanced Amino Acids (Igni Cognition) significantly outperformed both placebo and unenhanced supplements.
The initial test results and after every month are presented in tables and graphs. Tables show Number of errors in Schulte Tables test, Short-Term Memory test and Correction test with numbers that measure cognitive functions for the 3 groups in the study (enhanced, non-enhanced and placebo). Series 1 represent tests at the 0th day, series 2 at the 30th day, series 3 at the 60th day and series 4 at the 90th day. The table also contains the p values for the t-student test for a difference of the mean values over the 4 periods of time (0, 30, 60 and 90 days) in the study (T test 1-2 p value, T test 2-3 p value, T test 3-4 p value) (Figure 2).
Table 2 shows the number of errors in Shuttle tables tests for the 3 groups in the study during series 1, 2, 3 and 4. The number of errors measure the attention cognitive function (Figure 3).
|
Charged |
Uncharged |
Placebo |
T-test Enhanced- non-Enhanced P value |
Result from test 1 |
9.1 ± 2.1 |
11.2 ± 3.2 |
11.2 ± 3.6 |
0.72 |
Result from test 2 |
3.0 ± 0.4 |
9.1 ± 2.1 |
11.3 ± 3.1 |
0.04 |
Result from test 3 |
1.0 ± 0.3 |
3.0 ± 0.3 |
12.0 ± 2.7 |
<0.001 |
Result from test 4 |
1.0 ± 0.3 |
2.5 ± 0.2 |
11.9 ± 2.4 |
<0.001 |
T-test,1-2, p value |
< 0.001 |
< 0.001 |
0.96 |
|
T-test 2-3, p value |
< 0.05 |
< 0.001 |
0.87 |
|
T-test 3-4, p value |
0.99 |
0.76 |
0.84 |
|
Table 2: Number of errors in Schulte Tables (Attention).
Figure 2: Number of errors in Schulte Tables for series 1 (0th day), series 2 (30th day), 3 (60th day) and series 4 (90th day).
Table 3 shows the maximum length of presented number for the short-term memory test for the 3 groups in the study during series 1, 2, 3 and 4. This metric measures the memory cognitive function (Figure 3).
|
Charged |
Uncharged |
Placebo |
T-test Enhanced- non-Enhanced P value |
Result from test 1 |
6.5 ± 2.1 |
7.3 ± 1.9 |
7.5 ± 1.7 |
0.97 |
Result from test 2 |
8.6 ± 2.5 |
8.1 ± 2.6 |
7.6 ± 2.1 |
0.23 |
Result from test 3 |
10.3 ± 2.4 |
9.4 ± 3.0 |
7.3 ± 1.6 |
<0.001 |
Result from test 4 |
10.5 ± 2.6 |
9.6 ± 2.0 |
6.7 ± 2.2 |
0.05 |
T-test,1-2, p value |
< 0.001 |
< 0.001 |
0.84 |
|
T-test 2-3, p value |
< 0.001 |
< 0.001 |
0.76 |
|
T-test 3-4, p value |
0.76 |
0.82 |
0.09 |
|
Table 3: Short term memory (Memory).
Figure 3: Short term memory (Memory) results for series 1 (0th day), series 2 (30th day), 3 (60th day) and series 4 (90th day).
Table 4 shows the response time of Thorndike's test (seconds) for the 3 groups in the study during series 1, 2, 3 and 4. This metric measures the attention cognitive function (Figure 4).
|
Charged |
Uncharged |
Placebo |
T-test Enhanced- non-Enhanced P value |
|
Charged |
Uncharged |
Placebo |
T-test Charged-Uncharged |
Result from test 1 |
306.1 ± 67 |
327.2 ± 81 |
256.1 ± 65 |
0.56 |
Result from test 2 |
209.9 ± 34 |
249.7 ± 78 |
241.8 ± 63 |
0.12 |
Result from test 3 |
166.3 ± 36 |
192.9 ± 66 |
268.1 ± 57 |
<0.001 |
Result from test 4 |
121.6 ± 22 |
183.5 ± 34 |
270.0 ± 84 |
<0.001 |
T-test,1-2, p value |
< 0.001 |
< 0.001 |
0.86 |
|
T-test 2-3, p value |
< 0.001 |
< 0.001 |
0.97 |
|
T-test 3-4, p value |
< 0.001 |
0.08 |
0.89 |
|
Table 4: Time of Thorndike's test, seconds (Attention).
Figure 4: Response time of Thorndike's test for series 1 (0th day), series 2 (30th day), 3 (60th day) and series 4 (90th day).
Table 5 shows the total amount of missing numbers in the correction test for the 3 groups in the study during series 1, 2, 3 and 4. This metric measures the attention cognitive function (Figure 5).
|
Charged |
Uncharged |
Placebo |
T-test Enhanced- non-Enhanced P value |
Result from test 1 |
19.1 ± 2.3 |
18.2 ± 3.1 |
18.6 ± 2.6 |
0.67 |
Result from test 2 |
14.2 ± 2.1 |
16.0 ± 2.3 |
18.0 ± 2.3 |
0.06 |
Result from test 3 |
11.0 ± 1.9 |
15.0 ± 1.8 |
19.0 ± 3.1 |
<0.001 |
Result from test 4 |
9.0 ± 1.8 |
14.0 ± 1.7 |
19.0 ± 2.9 |
<0.001 |
T-test,1-2, p value |
< 0.001 |
< 0.001 |
0.09 |
|
T-test 2-3, p value |
< 0.001 |
< 0.001 |
0.08 |
|
T-test 3-4, p value |
< 0.001 |
< 0.001 |
0.96 |
|
Table 5: total amount of missing numbers in the correction test (Attention).
Figure 5: total amount of missing numbers in the correction test for series 1 (0th day), series 2 (30th day), 3 (60th day) and series 4 (90th day).
According to the Tables, the presented results show that an intake of AAs (Enhanced and non-Enhanced) has a positive effect in the memory function.
Intake of charged AAs has a positive effect in the speed of reactions function and this effect is present in the 60 to 90 days measurement while the effect of uncharged AAs reaches its maximum effect at 60 days. This last suggests that charged AAs have a more potential positive effect than uncharged AAs.
The Schulte tables test shows that that an intake of AAs (charged and uncharged) has a positive effect in the attention function, but this positive effect reaches its threshold at 60 days. However, Thorndike's test presents that an intake of charged AAs has a positive effect in the attention function and this effect is present in the 60 to 90 days measurement while the effect of uncharged AAs reaches its maximum effect at 60 days suggesting that charged AAs have a more potential positive effect than uncharged AAs. The difference of the results for both tests might be attributed to the better performance of the Thorndike's test to test attention [23].
While presented results demonstrate positive effect in cognitive functions for the intake of AAs in both combinations, the placebo group results practically did not change. This testifies that regular intake of the amino acid combinations positively affected cognitive function – memory, speed of reactions, and attention.
Amino acid enhanced by the cold plasma igniton/tachyon “charged” had an even more substantial effect, which correlates with the published data on food processing [15-19].
From all the results it is possible to see that for enhanced AAs to have better effect than uncharged AAs for memory, it takes at least 60 days. The results also show that the improvement because of the use of charged AAs continues after 90 days.
Enhanced AAs have better effect than uncharged AAs for speed of reactions after 30 days, but this effect reaches its maximum at 60 days and then stops being significant at 90 days.
As for the attention function, charged AAs have better performance than uncharged AAs after 30 days according to Schulte tables test but only after 60 days according to Thorndike's and Correction tests. The difference of the results for both tests might be attributed to the better performance of the Thorndike's test to test attention [23].
Results demonstrate better performance of enhanced AAs against non-enhanced AAs. One possible explanation for this additional solid effect of enhanced supplements on cognitive functions compared to intact supplements could be that cold plasma emits electromagnetic waves in a broad spectrum range, with emission peaks in the ultraviolet range [24]. At the same time, clinical effects were demonstrated not only by the radiation but also by fluids treated with this radiation [25,26]. In the food industry and medicine, the effect of irradiation of drugs in cold plasma is considered in terms of antimicrobial impacts; that is, it is an energy effect mainly due to high-energy ultraviolet photons. Our results cannot be considered from this point of view since this would mean introducing some additional properties in the structure of a substance, which are preserved for a long time. That is, additional hypotheses are required to explain the effects obtained. This suggests that in addition to the energetic impact of radiation, other mechanisms may be involved in the observed effects.
There are hypotheses that plasma radiation can generate a particular type of non-electromagnetic field - known as a tachyon or scalar field [27,28]. This field is associated with hypothetical particles - tachyons or ignitons, which have a size comparable to neutrinos and move at speed above the speed of light.
Presented results clearly demonstrate that the tests were better every month in both groups using amino acid combinations, while in the placebo group results practically did not change. This testifies that regular intake of the amino acid combinations positively affected cognitive function – memory, speed of reactions, and efficiency of information processing. Amino acid enhanced by the radiation of a cold plasma had an even more substantial effect, which correlates with the published data on food processing [29-33].
One wants to understand the reason for the significant effect after 30 days (see the Table 1) of enhanced supplements on cognitive functions compared to unenhanced supplements. This correlates with the hypotheses that plasma radiation can generate a particular type of non-electromagnetic field (or quasi-particles) - known as ignitons, related to tachyon or scalar field [34,35]. This field is associated with hypothetical quasi-particles - ignitons or tachyons, which have a size and speed comparable to neutrinos. Gerald Feinberg coined the term tachyon in 1967. He studied the kinematics of such particles according to special relativity. In his paper, he also introduced fields with imaginary mass (now referred to as tachyons) to understand the microphysical origin of such particles. Although in some theories, the mass of tachyons is regarded as imaginary, in some modern formulations, the mass is considered real, the formulas for the momentum and energy being redefined to this end. Moreover, since tachyons are constrained to the space-like portion of the energy–momentum graph, they could not slow down to subluminal (meaning slower-than-light) speeds. In 1985, Chodos proposed that neutrinos can have a tachyonic nature [36].
One limitation of this study is its lack of generalizability since it involved only one set of data. Many critics question the academic value of the case study method as they argue that the finding or results can not be generalized [34]. The limitations of this study include the sample size since we are using convenience sampling and this can compromise the accuracy of the results.
Longer period of times for the AAs intake would also be beneficial to find the thresholds for the positive effect for usage recommendation purposes.
Regular intake of AA compositions during the longitude period significantly affected cognitive functions: memory, speed of reactions, and attention. Amino acids enhanced in a cold plasma ignitons had an even more substantial effect and significantly faster, which may be interpreted as introducing additional properties into the substance of a substance itself.
Future research can be conducted to confirm this hypothesis with further studies of the structural properties of the preparations before and after irradiation.
Citation: Valverde R, Gavrilova E, Churganov O, Starchenko, Korotkov K (2023) Influence of Enhanced Amino Acid Compositions on Human Cognitive Functioning. J Altern Complement Integr Med 9: 377.
Copyright: © 2023 Valverde R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.